Allurion Technologies Inc. (NYSE:ALUR) Short Interest Update

Allurion Technologies Inc. (NYSE:ALUR) saw a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 526,100 shares, a decline of 11.5% from the May 31st total of 594,200 shares. Based on an average daily trading volume, of 2,060,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 1.7% of the company’s shares are short sold.

Allurion Technologies Stock Performance

Shares of Allurion Technologies stock remained flat at $1.26 during midday trading on Wednesday. The company had a trading volume of 554,382 shares, compared to its average volume of 1,125,208. The company’s 50 day moving average is $1.68 and its 200 day moving average is $2.43. The company has a market capitalization of $60.42 million, a P/E ratio of -0.33 and a beta of -0.29. Allurion Technologies has a one year low of $0.83 and a one year high of $9.00.

Allurion Technologies (NYSE:ALUR) last announced its earnings results on Tuesday, May 14th. The company reported $0.11 earnings per share for the quarter. The company had revenue of $9.39 million for the quarter. Research analysts anticipate that Allurion Technologies will post -0.65 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Allurion Technologies stock. RTW Investments LP purchased a new stake in shares of Allurion Technologies Inc. (NYSE:ALUR) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,457,707 shares of the company’s stock, valued at approximately $14,868,000. RTW Investments LP owned approximately 11.24% of Allurion Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 21.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital reaffirmed a “buy” rating and set a $5.00 price objective on shares of Allurion Technologies in a research note on Wednesday, May 15th.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.